- Home
- Publications
- Publication Search
- Publication Details
Title
Update on Management of Cancer-Related Cachexia
Authors
Keywords
Cancer, Cachexia, Quality of life, Muscle loss, Body weight, Nutrition, Inflammation, Appetite, Ghrelin, Exercise, Therapy, Multimodal, Clinical management
Journal
Current Oncology Reports
Volume 19, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-01-30
DOI
10.1007/s11912-017-0562-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Patient-reported outcomes, body composition, and nutrition status in patients with head and neck cancer: Results from an exploratory randomized controlled exercise trial
- (2016) Lauren C. Capozzi et al. CANCER
- A Prospective Randomized Controlled Trial to Study the Impact of a Nutrition-Sensitive Intervention on Adult Women With Cancer Cachexia Undergoing Palliative Care in India
- (2016) Neha Kapoor et al. INTEGRATIVE CANCER THERAPIES
- Cachexia in patients with cancer
- (2016) Grant R Williams et al. LANCET ONCOLOGY
- Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials
- (2016) Jennifer S Temel et al. LANCET ONCOLOGY
- Espindolol for the treatment and prevention of cachexia in patients with stage III/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial)
- (2016) Andrew J. Stewart Coats et al. Journal of Cachexia Sarcopenia and Muscle
- Ghrelin Partially Protects Against Cisplatin-Induced Male Murine Gonadal Toxicity in a GHSR-1a-Dependent Manner1
- (2015) Shannon D. Whirledge et al. BIOLOGY OF REPRODUCTION
- Cancer Cachexia, Recent Advances, and Future Directions
- (2015) Marie-France Penet et al. CANCER JOURNAL
- Xilonix, a novel true human antibody targeting the inflammatory cytokine interleukin-1 alpha, in non-small cell lung cancer
- (2015) David S. Hong et al. INVESTIGATIONAL NEW DRUGS
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Anamorelin for patients with cancer cachexia: an integrated analysis of two phase 2, randomised, placebo-controlled, double-blind trials
- (2015) José M Garcia et al. LANCET ONCOLOGY
- Aerobic exercise training as therapy for cardiac and cancer cachexia
- (2015) Christiano Robles Rodrigues Alves et al. LIFE SCIENCES
- Cachexia: clinical features when inflammation drives malnutrition
- (2015) Alessandro Laviano et al. PROCEEDINGS OF THE NUTRITION SOCIETY
- Muscle Quality in Aging: a Multi-Dimensional Approach to Muscle Functioning with Applications for Treatment
- (2015) Maren S. Fragala et al. SPORTS MEDICINE
- Exercise preferences, levels and quality of life in lung cancer survivors
- (2015) H. J. Leach et al. SUPPORTIVE CARE IN CANCER
- Request for regulatory guidance for cancer cachexia intervention trials
- (2015) KCH Fearon et al. Journal of Cachexia Sarcopenia and Muscle
- Ghrelin prevents tumour- and cisplatin-induced muscle wasting: characterization of multiple mechanisms involved
- (2015) Ji-an Chen et al. Journal of Cachexia Sarcopenia and Muscle
- A framework for prescription in exercise-oncology research
- (2015) John P. Sasso et al. Journal of Cachexia Sarcopenia and Muscle
- Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia
- (2015) Yu-Chou Tseng et al. JNCI-Journal of the National Cancer Institute
- Effects of an oral nutritional supplement containing eicosapentaenoic acid on nutritional and clinical outcomes in patients with advanced non-small cell lung cancer: Randomised trial
- (2014) Karla Sánchez-Lara et al. CLINICAL NUTRITION
- Do patients with advanced cancer have any potential for protein anabolism in response to amino acid therapy?
- (2014) Stéphanie Chevalier et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Multimodal nutrition/anabolic therapy for wasting conditions
- (2014) Trude Rakel Balstad et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- MABp1, a first-in-class true human antibody targeting interleukin-1α in refractory cancers: an open-label, phase 1 dose-escalation and expansion study
- (2014) David S Hong et al. LANCET ONCOLOGY
- Cancer Cachexia Syndrome: Pathogenesis, Diagnosis, and New Therapeutic Options
- (2014) Patrizia Mondello et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Phase I/II trial of formoterol fumarate combined with megestrol acetate in cachectic patients with advanced malignancy
- (2014) C. A. Greig et al. SUPPORTIVE CARE IN CANCER
- A prospective evaluation of an interdisciplinary nutrition–rehabilitation program for patients with advanced cancer
- (2013) B. Gagnon et al. Current Oncology
- Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial
- (2013) Adrian S Dobs et al. LANCET ONCOLOGY
- Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: A randomized controlled trial
- (2013) Alexandra Uster et al. NUTRITION
- Clinical development of ghrelin axis-derived molecules for cancer cachexia treatment
- (2013) Sumbul Ali et al. Current Opinion in Supportive and Palliative Care
- Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients
- (2012) Yuichiro Hiura et al. CANCER
- Current pharmacotherapy options for cancer anorexia and cachexia
- (2012) Antonio Macciò et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Role of Thalidomide and Placebo for the Treatment of Cancer-Related Anorexia-Cachexia Symptoms: Results of a Double-Blind Placebo-Controlled Randomized Study
- (2012) Sriram Yennurajalingam et al. JOURNAL OF PALLIATIVE MEDICINE
- Oral Nutritional Interventions in Malnourished Patients With Cancer: A Systematic Review and Meta-Analysis
- (2012) Christine Baldwin et al. JNCI-Journal of the National Cancer Institute
- L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN) - a randomized multicentre trial
- (2012) Matthias Kraft et al. Nutrition Journal
- Effects of exercise training on exercise capacity in patients with non-small cell lung cancer receiving targeted therapy
- (2012) Chueh-Lung Hwang et al. SUPPORTIVE CARE IN CANCER
- Therapeutic potential of anamorelin, a novel, oral ghrelin mimetic, in patients with cancer-related cachexia: a multicenter, randomized, double-blind, crossover, pilot study
- (2012) José M. Garcia et al. SUPPORTIVE CARE IN CANCER
- Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers
- (2012) Anne E. Utech et al. Journal of Cachexia Sarcopenia and Muscle
- Are there any benefits of exercise training in cancer cachexia?
- (2012) Josep M. Argilés et al. Journal of Cachexia Sarcopenia and Muscle
- Cancer cachexia prevention via physical exercise: molecular mechanisms
- (2012) Douglas W. Gould et al. Journal of Cachexia Sarcopenia and Muscle
- Randomized phase III clinical trial of a combined treatment with carnitine + celecoxib ± megestrol acetate for patients with cancer-related anorexia/cachexia syndrome
- (2011) Clelia Madeddu et al. CLINICAL NUTRITION
- Adipose tissue inflammation and cancer cachexia: Possible role of nuclear transcription factors
- (2011) M.L. Batista et al. CYTOKINE
- Poor tolerability of thalidomide in end-stage oesophageal cancer
- (2011) E.A. WILKES et al. EUROPEAN JOURNAL OF CANCER CARE
- Definition and classification of cancer cachexia: an international consensus
- (2011) Kenneth Fearon et al. LANCET ONCOLOGY
- Body composition in patients with non−small cell lung cancer: a contemporary view of cancer cachexia with the use of computed tomography image analysis
- (2010) Vickie E Baracos et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Effects by daily long term provision of ghrelin to unselected weight-losing cancer patients
- (2010) Kent Lundholm et al. CANCER
- Megestrol acetate in cancer anorexia and weight loss
- (2010) N. Simon Tchekmedyian et al. CANCER
- The “parallel pathway”: a novel nutritional and metabolic approach to cancer patients
- (2010) Maurizio Muscaritoli et al. Internal and Emergency Medicine
- Associations Among Hypogonadism, C-Reactive Protein, Symptom Burden, and Survival in Male Cancer Patients with Cachexia: A Preliminary Report
- (2010) Egidio Del Fabbro et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Phase II Study of the Novel Peptide-Nucleic Acid OHR118 in the Management of Cancer-Related Anorexia/Cachexia
- (2010) Martin Chasen et al. Journal of the American Medical Directors Association
- Randomized Phase III Clinical Trial of Five Different Arms of Treatment in 332 Patients with Cancer Cachexia
- (2010) G. Mantovani et al. ONCOLOGIST
- A.S.P.E.N. Clinical Guidelines: Nutrition Support Therapy During Adult Anticancer Treatment and in Hematopoietic Cell Transplantation
- (2009) David Allen August et al. JOURNAL OF PARENTERAL AND ENTERAL NUTRITION
- Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials
- (2009) Chantal Quinten et al. LANCET ONCOLOGY
- A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9)
- (2009) Aminah Jatoi et al. LUNG CANCER
- Mechanisms of Cancer Cachexia
- (2009) Michael J. Tisdale PHYSIOLOGICAL REVIEWS
- Steroidal Androgens and Nonsteroidal, Tissue-Selective Androgen Receptor Modulator, S-22, Regulate Androgen Receptor Function through Distinct Genomic and Nongenomic Signaling Pathways
- (2008) Ramesh Narayanan et al. MOLECULAR ENDOCRINOLOGY
- Cancer-related inflammation
- (2008) Alberto Mantovani et al. NATURE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started